Brian C. Grabiner
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, bioluminescence and chemiluminescence research, NF-κB Signaling Pathways, Fluorine in Organic Chemistry, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → The E3 Ligase TRAF6 Regulates Akt Ubiquitination and Activation(2009)687 cited
- → A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity(2014)451 cited
- → Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer(2014)325 cited
- → Germinal Center Selection and Affinity Maturation Require Dynamic Regulation of mTORC1 Kinase(2017)303 cited
- → Activating mTOR Mutations in a Patient with an Extraordinary Response on a Phase I Trial of Everolimus and Pazopanib(2014)280 cited
- → Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-κB and Snail(2007)247 cited
- → CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-κB activation(2007)122 cited
- → The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming(2015)87 cited
- → CARMA3 is Crucial for EGFR-Induced Activation of NF-κB and Tumor Progression(2011)86 cited
- → A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1(2013)80 cited